These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14329120)

  • 1. CARDIOVASCULAR FUNCTION IN PERITONEAL DIALYSIS.
    PACIFICO AD; LASKER N; FRANK MJ; LEVINSON GE
    Trans Am Soc Artif Intern Organs; 1965; 11():86-90. PubMed ID: 14329120
    [No Abstract]   [Full Text] [Related]  

  • 2. EXPERIENCES WITH THE LONG-TERM USE OF METHYLDOPA ("ALDOMET") IN HYPERTENSION.
    MEIRING PD
    Med J Aust; 1965 Mar; 1(12):416-9. PubMed ID: 14274397
    [No Abstract]   [Full Text] [Related]  

  • 3. PERIODIC PERITONEAL DIALYSIS IN CHRONIC RENAL INSUFFICIENCY.
    GUTCH CF; STEVENS SC; WATKINS FL
    Ann Intern Med; 1964 Feb; 60():289-96. PubMed ID: 14114448
    [No Abstract]   [Full Text] [Related]  

  • 4. PERITONEAL DIALYSIS AND RENAL FAILURE.
    WILSON JD; CAMPION DS; NORTH JD
    N Z Med J; 1965 Jan; 64():7-14. PubMed ID: 14259629
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of alpha-methyldopa and guanethidine on hemodynamic shifts in the orthostatic position in patients with arterial hypertension].
    Glezer GA; Moskalenko NP
    Kardiologiia; 1972 Dec; 12(12):55-60. PubMed ID: 4661921
    [No Abstract]   [Full Text] [Related]  

  • 6. Periodic dialysis in terminal uremia.
    Abella R; Blondeel NJ; Roguska J; Walker C; Simon NM; Del Greco F
    JAMA; 1967 Feb; 199(6):362-8. PubMed ID: 4289324
    [No Abstract]   [Full Text] [Related]  

  • 7. PERIODIC PERITONEAL DIALYSIS FOR CHRONIC RENAL FAILURE. A CASE STUDY OF SIXTEEN MONTHS' EXPERIENCE.
    SCHUMACHER RR; RIDOLFO AS; MARTZ BL
    Ann Intern Med; 1964 Feb; 60():296-305. PubMed ID: 14114449
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EFFECTS OF GUANETHIDINE AND OF ALPHA-METHYLDOPA ON THE DIGITAL CIRCULATION IN HYPERTENSION.
    MENDLOWITZ M; NAFTCHI NE; WOLF RL; GITLOW SE
    Am Heart J; 1965 Jun; 69():731-9. PubMed ID: 14296639
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma renin activity in end-stage kidney disease.
    Gutkin M; Levinson GE; King AS; Lasker N
    Circulation; 1969 Oct; 40(4):563-74. PubMed ID: 5823552
    [No Abstract]   [Full Text] [Related]  

  • 10. HEMODYNAMIC RESPONSE TO ANTIHYPERTENSIVE DRUG THERAPY.
    BREST AN
    JAMA; 1965 Apr; 192():41-4. PubMed ID: 14262269
    [No Abstract]   [Full Text] [Related]  

  • 11. PRESSOR RESPONSES TO NOXIOUS STIMULI IN HYPERTENSIVE PATIENTS: EFFECTS OF GUANETHIDINE SULFATE AND ALPHA METHYLDOPA.
    SHAPIRO AP; KRIFCHER E
    Circulation; 1964 Nov; 30():671-8. PubMed ID: 14230935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Glezer GA
    Kardiologiia; 1968 Aug; 8(8):113-8. PubMed ID: 5727457
    [No Abstract]   [Full Text] [Related]  

  • 13. [INTERMITTENT PERITONEAL DIALYSIS].
    JIRKA J; FENCL V; HURYCH J; HORNYCH A
    Cas Lek Cesk; 1964 Nov; 103():1289-99. PubMed ID: 14223769
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL PROBLEMS OF KIDNEY TRANSPLANTATIONS IN HUMANS].
    BROSIG W; NAGEL R
    Urologe; 1965 Jan; 4():1-8. PubMed ID: 14276479
    [No Abstract]   [Full Text] [Related]  

  • 15. GUANETHIDINE AND METHYLDOPA: A HAEMODYNAMIC STUDY.
    CHAMBERLAIN DA; HOWARD J
    Br Heart J; 1964 Jul; 26(4):528-36. PubMed ID: 14196136
    [No Abstract]   [Full Text] [Related]  

  • 16. [SEVERE FORMS OF ACUTE GLOMERULONEPHRITIS. (3 CLINICAL CASES)].
    GARCIAANTILLON L; SEGUIASSALAZAR N; GORDILLO G
    Bol Med Hosp Infant Mex; 1963; 20():787-91. PubMed ID: 14107059
    [No Abstract]   [Full Text] [Related]  

  • 17. THE MANAGEMENT OF END-STAGE KIDNEY DISEASE WITH INTERMITTENT PERITONEAL DIALYSIS.
    LASKER N; SHALHOUB R; HABIBE O; PASSAROTTI C
    Ann Intern Med; 1965 Jun; 62():1147-69. PubMed ID: 14295499
    [No Abstract]   [Full Text] [Related]  

  • 18. OBSERVATIONS CONCERNING THE USE OF LYMPH FOR EXTRACORPOREAL DIALYSIS.
    SARLES HE; ARTZ CP; SMITH GH; HARGEST TS; REMMERS AR
    Trans Am Soc Artif Intern Organs; 1965; 11():165-72. PubMed ID: 14329078
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I; Yuzhakov S
    Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PERITONEAL DIALYSIS IN THE MANAGEMENT OF CHRONIC RENAL FAILURE.
    STEVENS RE; BASKIN S; GREENE JA; WELLER JM
    JAMA; 1964 Dec; 190():1128-30. PubMed ID: 14212307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.